Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LEVODOPA vs LEVOSIMENDAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LEVODOPA vs LEVOSIMENDAN: Safety Overview

Metric LEVODOPA LEVOSIMENDAN
Total FAERS Reports 6,610 183
Deaths Reported 546 37
Death Rate 8.3% 20.2%
Hospitalizations 729 103
Average Patient Age 69.3 yrs 49.9 yrs
% Female Patients 42.9% 42.5%
FDA Approval Date Approved Prior to Jan 1, 1982 N/A
Manufacturer Deseret Biologicals, Inc. N/A
Route ORAL N/A
Marketing Status Discontinued N/A